# Methotrexate in the Treatment of Axial Spondyloarthritis

> **NCT00298012** · PHASE4 · WITHDRAWN · sponsor: **Rheumatism Foundation Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Spondylarthropathies
- Spondylitis, Ankylosing

## Interventions

- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT00298012
- **Lead sponsor:** Rheumatism Foundation Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2009-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00298012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00298012, "Methotrexate in the Treatment of Axial Spondyloarthritis". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00298012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*